Results 31 to 40 of about 1,040,958 (268)

Azole-Induced Myositis after Combined Lung-Liver Transplantation

open access: yesCase Reports in Transplantation, 2022
Lung transplant recipients experience a high rate of invasive pulmonary aspergillosis infections, for which voriconazole is the treatment of choice.
Sofie Happaerts   +7 more
doaj   +1 more source

Potential role of saffron and its components on miRNA levels in various disorders, a comprehensive review [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2023
The potential therapeutic benefits of saffron and its active constituents have been investigated for the treatment of numerous illnesses. In this review, the impacts of saffron and its essential components on the levels of microRNAs (miRNAs) in different
Mohammad Reza Aslani   +4 more
doaj   +1 more source

Parasitic lung diseases

open access: yesEuropean Respiratory Review, 2022
Parasitic lung diseases are caused by a number of parasites as a result of transient passage in the lung or as a result of an immunologic reaction. The clinical presentation may be in the form of focal or cystic lesions, pleural effusion or diffuse pulmonary infiltrates. With increasing globalisation, it is important to consider parasitic infections in
Jaffar A. Al-Tawfiq   +2 more
openaire   +3 more sources

Novel folliculin gene mutations in Polish patients with Birt–Hogg–Dubé syndrome

open access: yesOrphanet Journal of Rare Diseases, 2021
Background Birt–Hogg–Dubé syndrome (BHDS) is a rare, autosomal dominant, inherited disease caused by mutations in the folliculin gene (FLCN). The disease is characterised by skin lesions (fibrofolliculomas, trichodiscomas, acrochordons), pulmonary cysts ...
Elżbieta Radzikowska   +3 more
doaj   +1 more source

Non-Tuberculous Mycobacteria in Respiratory Specimens of Patients with Obstructive Lung Diseases—Colonization or Disease?

open access: yesAntibiotics, 2020
Non-tuberculous mycobacteria (NTM) are increasingly a cause of human respiratory tract colonization and mycobacterial lung disease (NTM-LD), especially in patients with chronic lung diseases.
Monika Szturmowicz   +5 more
doaj   +1 more source

Interstitial lung disease [PDF]

open access: yesEuropean Respiratory Review, 2014
Interstitial lung diseases are a group of diffuse parenchymal lung disorders associated with substantial morbidity and mortality. Knowledge achieved in recent years has resulted in the publication of the new classification of idiopathic interstitial pneumonias, according to which there are three groups: major, rare and unclassified.
Antoniou, Katerina M.   +5 more
openaire   +4 more sources

A multicentre retrospective observational study on Polish experience of pirfenidone therapy in patients with idiopathic pulmonary fibrosis: the PolExPIR study

open access: yesBMC Pulmonary Medicine, 2020
Background Pirfenidone is an antifibrotic agent approved for the treatment of idiopathic pulmonary fibrosis (IPF). The drug is available for Polish patients with IPF since 2017. The PolExPIR study aimed to describe the real-world data (RWD) on the Polish
Sebastian Majewski   +25 more
doaj   +1 more source

Large Pericardial Effusion—Diagnostic and Therapeutic Options, with a Special Attention to the Role of Prolonged Pericardial Fluid Drainage

open access: yesDiagnostics, 2022
Background: Large pericardial effusion (LPE) is associated with high mortality. In patients with cardiac tamponade or with suspected bacterial etiology of pericardial effusion, urgent pericardial decompression is necessary.
Małgorzata Dybowska   +7 more
doaj   +1 more source

Lung Ultrasonography in the Evaluation of Late Sequelae of COVID-19 Pneumonia—A Comparison with Chest Computed Tomography: A Prospective Study

open access: yesViruses
The onset of the COVID-19 pandemic allowed physicians to gain experience in lung ultrasound (LUS) during the acute phase of the disease. However, limited data are available on LUS findings during the recovery phase.
Katarzyna Zimna   +6 more
doaj   +1 more source

Both T and B cells are indispensable for the development of a PBMC transfer-induced humanized mouse model for SSc

open access: yesArthritis Research & Therapy, 2022
Background Recently, a novel humanized mouse model for systemic sclerosis (SSc) was established by transferring peripheral blood mononuclear cells (PBMC) from patients with SSc to Rag2 −/− Il2rg −/− immunodeficient mice. Here, we aimed to investigate the
Yaqing Shu   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy